Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat
The drug Tarceva, made by OSI Pharmaceuticals has been found to cause an increase in survival rates in lung cancer patients when the drug is administered after chemotherapy treatments. The chief executive officer of the company, Colin Goddard, was pleased to announce the results. This drug may be the first in a wave of new treatments for cancer.
This drug works by stopping the growth of non small cell cancer cells, which then slows and even eliminates the cancer?s spread throughout the body. The study involved 889 patients who were given at least four cycles chemotherapy and were then treated with either once-daily Tarceva or a placebo if the disease did not progress during chemotherapy.